Neuroprotection of Recombinant Human Erythropoietin Via Modulation of N-methyl-D-aspartate Receptors in Neonatal Rats with Hypoxic-ischemic Brain Injury
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose : Erythropoietin (EPO) has neuroprotective effects in many animal models of brain injury, including hypoxic-ischemic (HI) encephalopathy, trauma, and excitotoxicity. Current studies have demonstrated the neuroprotective effects of EPO, but limited data are available for the neonatal periods. Here in we investigated whether recombinant human EPO (rHuEPO) can protect the developing rat brain from HI injury via modulation of NMDA receptors. Methods : In an in vitro model, embryonic cortical neuronal cell cultures from Sprague- Dawley (SD) rats at 19-days gestation were established. The cultured cells were divided into five groups: normoxia (N), hypoxia (H), and 1, 10, and 100 IU/mL rHuEPO-treated (H+E1, H+ E10, and H+E100) groups. To estimate cell viability and growth, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay was done. In an in vivo model, left carotid artery ligation was performed on 7-day-old SD rat pups. The animals were divided into six groups; normoxia control (NC), normoxia Sham-operated (NS), hypoxia- ischemia only (H), hypoxia-ischemia+vehicle (HV), hypoxia-ischemia+rHuEPO before a HI injury (HE-B), and hypoxia-ischemia+rHuEPO after a HI injury (HE-A). The morphologic changes following brain injuries were noted using hematoxylin and eosin (H/E) staining. Real-time PCR using primers of subunits of NMDA receptors (NR1, NR2A, NR2B, NR2C and NR2D) mRNA were performed. Results : Cell viability in the H group was decreased to less than 60% of that in the N group. In the H+E1 and H+E10 groups, cell viability was increased to >80% of the N group, but cell viability in the H+E100 group did not recover. The percentage of the left hemisphere area compared the to the right hemisphere area were 98.9% in the NC group, 99.1% in the NS group, 57.1% in the H group, 57.0% in the HV group, 87.6% in the HE-B group, and 91.6% in the HE-A group. Real-time PCR analysis of the expressions of subunits of NMDA receptors mRNAs in the in vitro and in vivo neonatal HI brain injuries generally revealed that the expression in the H group was decreased compared to the N group and the expressions in the rHuEPO-treated groups was increased compared to the H group. Conclusion : rHuEPO has neuroprotective property in perinatal HI brain injury via modulation of N-methyl-D-aspartate receptors.
Abstract
Purpose : Erythropoietin (EPO) has neuroprotective effects in many animal models of brain injury, including hypoxic-ischemic (HI) encephalopathy, trauma, and excitotoxicity. Current studies have demonstrated the neuroprotective effects of EPO, but limited data are available for the neonatal periods. Here in we investigated whether recombinant human EPO (rHuEPO) can protect the developing rat brain from HI injury via modulation of NMDA receptors. Methods : In an in vitro model, embryonic cortical neuronal cell cultures from Sprague- Dawley (SD) rats at 19-days gestation were established. The cultured cells were divided into five groups: normoxia (N), hypoxia (H), and 1, 10, and 100 IU/mL rHuEPO-treated (H+E1, H+ E10, and H+E100) groups. To estimate cell viability and growth, a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay was done. In an in vivo model, left carotid artery ligation was performed on 7-day-old SD rat pups. The animals were divided into six groups; normoxia control (NC), normoxia Sham-operated (NS), hypoxia- ischemia only (H), hypoxia-ischemia+vehicle (HV), hypoxia-ischemia+rHuEPO before a HI injury (HE-B), and hypoxia-ischemia+rHuEPO after a HI injury (HE-A). The morphologic changes following brain injuries were noted using hematoxylin and eosin (H/E) staining. Real-time PCR using primers of subunits of NMDA receptors (NR1, NR2A, NR2B, NR2C and NR2D) mRNA were performed. Results : Cell viability in the H group was decreased to less than 60% of that in the N group. In the H+E1 and H+E10 groups, cell viability was increased to >80% of the N group, but cell viability in the H+E100 group did not recover. The percentage of the left hemisphere area compared the to the right hemisphere area were 98.9% in the NC group, 99.1% in the NS group, 57.1% in the H group, 57.0% in the HV group, 87.6% in the HE-B group, and 91.6% in the HE-A group. Real-time PCR analysis of the expressions of subunits of NMDA receptors mRNAs in the in vitro and in vivo neonatal HI brain injuries generally revealed that the expression in the H group was decreased compared to the N group and the expressions in the rHuEPO-treated groups was increased compared to the H group. Conclusion : rHuEPO has neuroprotective property in perinatal HI brain injury via modulation of N-methyl-D-aspartate receptors.
참고문헌 (40)
- Juul S, "Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models", Clin Perinatol, 31, pp.129~142 (2004)
- Siren AL, "Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress", Proc Natl Acad Sci U S A, 통권 : 98, pp.4044~4049 (2001)
- Marti HH, "Erythropoietin gene expression in human monkey and murine brain", Eur J Neurosci, 8, pp.666~676 (1996)
- Wen TC, "Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by upregulating Bcl-xL expression", J Neurosci Res, 67, pp.795~803 (2002)
- Koshimura K, "Effects of erythropoietin on neuronal activity", J Neurochem, 72, pp.2565~2572 (1999)
- Calapai G, "Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation", Eur J Pharmacol, 401, pp.349~356 (2000)
- Kawakami M, "Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia", J Biol Chem, 276, pp.39469~39475 (2001)
- Ghezzi P, "Erythropoietin as an antiapoptotic, tissue-protective cytokine", Cell Death Differ, 11, pp.S37~S44 (2004)
- Chakraborty M, "Effect of erythropoietin on membrane lipid peroxidation, superoxide dismutase, catalase and glutathione peroxidase of rat RBC", Biochem Med Metab Biol, 40, pp.8~18 (1988)
- Atlason PT, "N-Methyl-D-aspartate (NMDA) receptor subunit NR1 forms the substrate for oligomeric assembly of the NMDA receptor", J Biol Chem, 282, pp.25299~25307 (2007)
- Kuryatov A, "Mutational analysis of the glycine-binding site of the NMDA receptor: structural similarity with bacterial amino acid-binding proteins", Neuron, 12, pp.1291~1300 (1994)
- Laube B, "Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit", Neuron, 18, pp.493~503 (1997)
- Perez-Otano I, "Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors", J Neurosci, 21, pp.1228~1237 (2001)
- Dzietko M, "Erythropoietin protects the developing brain against N-methyl- d-aspartate receptor antagonist neurotoxicity", Neurobiol Dis, 15, pp.177~187 (2004)
- Sinor AD, "Erythropoietin protects cultured cortical neurons, but not astroglia, from hypoxia and AMPA toxicity", Neurosci Lett, 290, pp.213~215 (2000)
- Brewer GJ, "Isolation and culture of adult rat hippocampal neurons", J Neurosci Meth, 71, pp.143~155 (1997)
- Mosmann T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J Immunol Methods, 65, pp.55~63 (1983)
- Rice JE 3rd, "The influence of immaturity on hypoxic-ischemic brain damage in the rat", Ann Neurol, 9, pp.131~141 (1981)
- Iwai M, "Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia", ischemia in rats, 2007, pp.38, 2795~2803
- Vannucci RC, "Interventions for perinatal hypoxic-ischemic encephalopathy", Pediatrics, 100, pp.1004~1014 (1997)
- Volpe JJ, "Perinatal brain injury: from pathogenesis to neuroprotection", Ment Retard Dev Disabil Res Rev, 7, pp.56~64 (2001)
- Anderson P, "Victorian Infant Collaborative Study Group Neurobehavioral outcomes of school-age children born extremely low birth weight or very preterm in the 1990s", JAMA, 289, pp.3264~3272 (2003)
- Martin LJ, "Mechanism of brain damage in animal models of hypoxia-ischemia in newborns. in: Fetal and Neonatal Brain Injury: Mechamism, management, and the Risks of Practice", pp.30~57 (2003), Oxford University Press
- Ashwal S, "Animal models of neonatal stroke", Curr Opin Pediatr, 13, pp.506~516 (2001)
- Jelkmann W, "Erythropoietin: structure, control of production, and function", Physiol Rev, 72, pp.449~489 (1992)
- Marti HH, "Neuro protection and angiogenesis: dual role of erythropoietin in brain ischemia", News Physiol. Sci, 15, pp.225~229 (2000)
- Spandou E, "Erythropoietin prevents hypoxia", ischemia-induced DNA fragmentation in an experimental model of perinatal asphyxia, 2004, pp.366, 24~28
- Ruscher K, "Erythropoietin is a paracrine mediator of ischemic tolerance in the brain, evidence from an in vitro model", J Neurosci, 22, pp.10291~10301 (2002)
- Grimm C, "Constitutive overexpression of human erythropoietin protects the mouse retina against induced but not inherited retinal degeneration", J Neurosci, 24, pp.5651~5658 (2004)
- Spandou E, "Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats", Brain Res, 1045, pp.22~30 (2005)
- 김행미, "편마비를 가진 뇌성마비 환아에서 확산 텐서강조영상을 Erythropoietin의 투여가 신생백서 저산소허혈뇌손상에 미치는 영향", Korean Journal of Pediatrics, 52(1), pp.105~110 (2009), 대한소아과학회
- Villa P, "Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis", J Exp, 198, pp.971~975 (2003)
- Naito S, "Adenosine triphosphate-dependent uptake of glutamate into protein I-associated synaptic vesicles", J Biol Chem, 258, pp.696~699 (1983)
- Dienel GA, "Astrocytic contributions to bioenergetics of cerebral ischemia", Glia, 50, pp.362~388 (2005)
- Hestrin S, "Developmental regulation of NMDA receptor-mediated synaptic currents at a central synapse", Nature, 357, pp.686~689 (1992)
- Wu G, "Maturation of a central glutamatergic synapse", Science, 274, pp.972~976 (1996)
- Hwang JY, "N-Methyl-D-aspartate receptor blockade induces neuronal apoptosis in cortical culture", Exp Neurol, 159, pp.124~130 (1999)
- Ikonomidou C, "Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain", Science, 283, pp.70~74 (1999)
- Sung Shin Kim, "Erythropoietin Attenuates Brain Injury, Subventricular Zone Expansion, and Sensorimotor Deficits in Hypoxic-Ischemic Neonatal Rats", Journal of Korean Medical Science, 23(3), pp.484~491 (2008), 대한의학회
- Yang SH, "The Expression of Isoforms of Nitric Oxide Synthase (NOS) and Subunits of N-methyl- D-aspartate (NMDA) Receptor according to Administration of Mycophenolic Acid before or after Perinatal Hypoxic Ischemic Brain Injury", J Korean Soc Neonatol, 14, pp.1~10 (2007)